A carregar...
Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19). Since its emergence, the COVID-19 pandemic has not only distressed medical services but also caused economic upheavals, marking urgent the need for effective therapeutics. The experie...
Na minha lista:
| Publicado no: | J Enzyme Inhib Med Chem |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7808739/ https://ncbi.nlm.nih.gov/pubmed/33430659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2020.1850710 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|